WallStreetZenWallStreetZen

NYSE: COR
Cencora Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for COR

Based on 11 analysts offering 12 month price targets for Cencora Inc

Min Forecast
$360.00+2.08%
Avg Forecast
$407.55+15.57%
Max Forecast
$440.00+24.77%

Should I buy or sell COR stock?

Based on 11 analysts offering ratings for Cencora Inc.

Strong Buy
Strong Buy
7 analysts 63.64%
Buy
3 analysts 27.27%
Hold
1 analysts 9.09%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although COR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates COR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their COR stock forecasts and price targets.

COR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-13
lockedlocked$00.00+00.00%2026-02-10Find Out Why
lockedlocked$00.00+00.00%2026-02-10
lockedlocked$00.00+00.00%2026-02-05
lockedlocked$00.00+00.00%2026-01-29
Jefferies
Top 14%
87
Strong BuyUpgrades$440.00+24.77%2026-01-22Find out why
Bank of America
Bottom 6%
6
HoldMaintains$360.00+2.08%2026-01-05
TD Cowen
Bottom 5%
5
Strong BuyMaintains$400.00+13.43%2025-11-10
UBS
Top 19%
82
Strong BuyMaintains$415.00+17.68%2025-11-07Find out why
Baird
Top 17%
84
BuyMaintains$395.00+12.01%2025-11-06

1 of 2

Forecast return on equity

Is COR forecast to generate an efficient return?

Company
252.24%
Industry
-208.49%
Market
180.91%
COR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is COR forecast to generate an efficient return on assets?

Company
6.14%
Industry
7.17%
COR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COR earnings per share forecast

What is COR's earnings per share in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$17.80+112.35%
Avg 2 year Forecast
$19.89+137.36%
Avg 3 year Forecast
$22.05+163.11%
COR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

COR revenue forecast

What is COR's revenue in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$350.2B+7.48%
Avg 2 year Forecast
$373.8B+14.75%
Avg 3 year Forecast
$398.9B+22.45%
COR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

COR earnings growth forecast

How is COR forecast to perform vs Medical Distribution companies and vs the US market?

Company
38.03%
Industry
22.7%
Market
36.28%
COR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
COR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
COR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

COR revenue growth forecast

How is COR forecast to perform vs Medical Distribution companies and vs the US market?

Company
6.96%
Industry
6.9%
Market
13.49%
COR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
COR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

COR vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
COR$352.65$407.55+15.57%Strong Buy
CAH$219.09$238.44+8.83%Strong Buy
MCK$944.36$930.23-1.50%Strong Buy
HSIC$74.97$88.50+18.05%Buy
AHG$1.35N/AN/A
View Top Medical Distribution Stocks

Cencora Stock Forecast FAQ

Is Cencora Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: COR) stock is to Strong Buy COR stock.

Out of 11 analysts, 7 (63.64%) are recommending COR as a Strong Buy, 3 (27.27%) are recommending COR as a Buy, 1 (9.09%) are recommending COR as a Hold, 0 (0%) are recommending COR as a Sell, and 0 (0%) are recommending COR as a Strong Sell.

If you're new to stock investing, here's how to buy Cencora stock.

What is COR's earnings growth forecast for 2026-2028?

(NYSE: COR) Cencora's forecast annual earnings growth rate of 38.03% is forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 22.7%, and it is also forecast to beat the US market's average forecast earnings growth rate of 36.28%.

Cencora's earnings in 2026 is $1,625,216,000.On average, 20 Wall Street analysts forecast COR's earnings for 2026 to be $3,461,731,845, with the lowest COR earnings forecast at $3,326,669,193, and the highest COR earnings forecast at $3,641,906,163. On average, 19 Wall Street analysts forecast COR's earnings for 2027 to be $3,869,293,077, with the lowest COR earnings forecast at $3,646,944,508, and the highest COR earnings forecast at $4,170,932,353.

In 2028, COR is forecast to generate $4,289,109,742 in earnings, with the lowest earnings forecast at $3,972,939,025 and the highest earnings forecast at $4,571,276,496.

What is COR's revenue growth forecast for 2026-2028?

(NYSE: COR) Cencora's forecast annual revenue growth rate of 6.96% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.49%.

Cencora's revenue in 2026 is $325,777,775,000.On average, 19 Wall Street analysts forecast COR's revenue for 2026 to be $68,115,112,832,982, with the lowest COR revenue forecast at $65,635,235,698,846, and the highest COR revenue forecast at $71,106,411,130,096. On average, 17 Wall Street analysts forecast COR's revenue for 2027 to be $72,721,988,444,106, with the lowest COR revenue forecast at $69,046,914,799,762, and the highest COR revenue forecast at $77,054,770,324,292.

In 2028, COR is forecast to generate $77,598,289,049,800 in revenue, with the lowest revenue forecast at $73,369,775,615,166 and the highest revenue forecast at $83,570,770,048,564.

What is COR's forecast return on assets (ROA) for 2026-2029?

(NYSE: COR) forecast ROA is 6.14%, which is lower than the forecast US Medical Distribution industry average of 7.17%.

What is COR's Price Target?

According to 11 Wall Street analysts that have issued a 1 year COR price target, the average COR price target is $407.55, with the highest COR stock price forecast at $440.00 and the lowest COR stock price forecast at $360.00.

On average, Wall Street analysts predict that Cencora's share price could reach $407.55 by Feb 13, 2027. The average Cencora stock price prediction forecasts a potential upside of 15.57% from the current COR share price of $352.65.

What is COR's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: COR) Cencora's current Earnings Per Share (EPS) is $8.38. On average, analysts forecast that COR's EPS will be $17.80 for 2026, with the lowest EPS forecast at $17.10, and the highest EPS forecast at $18.72. On average, analysts forecast that COR's EPS will be $19.89 for 2027, with the lowest EPS forecast at $18.75, and the highest EPS forecast at $21.44. In 2028, COR's EPS is forecast to hit $22.05 (min: $20.42, max: $23.50).

What is COR's forecast return on equity (ROE) for 2026-2029?

(NYSE: COR) forecast ROE is 252.24%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.